Era Mandiri Cemerlang Tbk. vs Ikapharmindo Putramas Tbk. — how do they compare? Era Mandiri Cemerlang Tbk. trades at Rp87 (market cap 74.17B, 27.3M 24h volume), while Ikapharmindo Putramas Tbk. trades at Rp197 (market cap 330.19B, 135.9K 24h volume). The key difference: Ikapharmindo Putramas Tbk. is far larger — about 4.5× Era Mandiri Cemerlang Tbk.'s market cap, and Era Mandiri Cemerlang Tbk. is more actively traded (27.3M versus 135.9K). Which is the better fit depends on your goals.
| IKAN | IKPM | |
|---|---|---|
Market Cap | 74.17B | 330.19B |
Volume | 27.3M | 135.9K |
Lot | 272.96K | 1.36K |
Turnover | 2.47B | 26.77M |
Average Price | 90.46 | 197 |
Value | 2.47B | 26.77M |
Indicative Equilibrium Price | 89 | 195 |
Indicative Equilibrium Volume | 71.5K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Era Mandiri Cemerlang Tbk ("Company") was established with Deed Number 79, 14 November 2000 by Haji Muhammad Afdal Gazali, SH., a public notary in Jakarta.
Read more on IKAN →PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →